Anne Lennard

4.4k total citations
51 papers, 1.6k citations indexed

About

Anne Lennard is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Anne Lennard has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 23 papers in Genetics and 19 papers in Oncology. Recurrent topics in Anne Lennard's work include Lymphoma Diagnosis and Treatment (26 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (12 papers). Anne Lennard is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Viral-associated cancers and disorders (12 papers). Anne Lennard collaborates with scholars based in United Kingdom, United States and France. Anne Lennard's co-authors include Stephen J. Proctor, Michal Sieniawski, R.J. Prescott, Oliver W. Press, Nathan Fowler, Bruce D. Cheson, Pieternella J. Lugtenburg, Neil Chua, Jiřı́ Mayer and Greg Dueck and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anne Lennard

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Lennard United Kingdom	20	831	562	561	414	240	51	1.6k
G. Pagnucco Italy	23	565 0.7×	589 1.0×	486 0.9×	579 1.4×	180 0.8×	69	1.4k
DC Linch United Kingdom	19	949 1.1×	397 0.7×	720 1.3×	229 0.6×	241 1.0×	37	1.5k
Piero Galieni Italy	26	700 0.8×	564 1.0×	706 1.3×	739 1.8×	275 1.1×	89	1.7k
Surender Juneja Australia	20	541 0.7×	538 1.0×	375 0.7×	489 1.2×	168 0.7×	85	1.3k
Judit Demeter Hungary	18	553 0.7×	562 1.0×	413 0.7×	426 1.0×	269 1.1×	117	1.6k
Benet Nomdedeu Spain	22	592 0.7×	829 1.5×	349 0.6×	881 2.1×	285 1.2×	88	1.8k
Nicola Di Renzo Italy	24	944 1.1×	631 1.1×	681 1.2×	531 1.3×	275 1.1×	98	1.9k
P. M. Kluin Netherlands	21	1.0k 1.2×	431 0.8×	797 1.4×	260 0.6×	314 1.3×	40	1.8k
Carlos Panizo Spain	19	538 0.6×	398 0.7×	463 0.8×	287 0.7×	276 1.1×	93	1.5k
J R Redman United States	24	1.2k 1.4×	1.1k 1.9×	662 1.2×	315 0.8×	436 1.8×	34	2.1k

Countries citing papers authored by Anne Lennard

Since Specialization

Citations

This map shows the geographic impact of Anne Lennard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lennard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lennard more than expected).

Fields of papers citing papers by Anne Lennard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Lennard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lennard. The network helps show where Anne Lennard may publish in the future.

Co-authorship network of co-authors of Anne Lennard

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Lennard. A scholar is included among the top collaborators of Anne Lennard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Lennard. Anne Lennard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sehn, Laurie H., Neil Chua, Jiřı́ Mayer, et al.. (2016). Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial. The Lancet Oncology. 17(8). 1081–1093. 227 indexed citations

Berkhof, Johannes, Michal Sieniawski, Wieke H.M. Verbeek, et al.. (2015). A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma. Clinical Cancer Research. 21(13). 3013–3019. 18 indexed citations

Burns, David, Jennifer Marsh, Martin Rowe, et al.. (2013). Outcomes With Rituximab Monotherapy Versus R-CHOP In Post-Transplant Lymphoproliferative Disease Arising After Solid Organ Transplant: A Multicentre UK Study. Blood. 122(21). 3043–3043. 1 indexed citations

Jovanović, Jelena, Dominic Culligan, Andrew Peniket, et al.. (2011). Development of Real-Time Quantitative Polymerase Chain Reaction Assays to Track Treatment Response in Retinoid Resistant Acute Promyelocytic Leukemia. SHILAP Revista de lepidopterología. 1. 35–35. 18 indexed citations

Proctor, S.J., Anne Lennard, Graham Jackson, et al.. (2009). The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control. Annals of Oncology. 21(2). 426–428. 7 indexed citations

Proctor, S.J., G Jackson, Anne Lennard, et al.. (2003). Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK). Annals of Oncology. 14. i47–i50. 24 indexed citations

Drummond, Mark W., David Marin, Richard E. Clark, et al.. (2003). Mobilization of Ph chromosome‐negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate‐induced complete cytogenetic remission. British Journal of Haematology. 123(3). 479–483. 14 indexed citations

Feng, Liang, Mark W. Drummond, Jenny Byrne, et al.. (2002). Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.. Blood. 100(11). 1425. 7 indexed citations

James, Steve A., Anne Lennard, A. Galloway, et al.. (2002). Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients. Journal of Hospital Infection. 52(4). 268–272. 18 indexed citations

10.

Proctor, S.J., M. Mackie, R.J. Prescott, et al.. (2002). A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III). European Journal of Cancer. 38(6). 795–806. 30 indexed citations

11.

Lennard, Anne. (2001). The Lymphoproliferative Disorders.. Journal of Clinical Pathology. 54(1). 80.1–80. 4 indexed citations

12.

Cavet, Jim, Anne Lennard, A. Gascoigne, et al.. (2000). Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplantation. 25(5). 571–573. 14 indexed citations

13.

Jackson, Graham, Brian Angus, Peter Carey, et al.. (2000). High Dose Ifosfamide in Combination with Etoposide and Epirubicin Followed by Autologous Stem Cell Transplantation in the Treatment of Relapsecd/Refractory Hodgkin's Disease: a Report on Toxicity and Efficacy On behalf of the Scotland and Newcastle Lymphoma Group. Leukemia & lymphoma. 37(5-6). 561–570. 7 indexed citations

14.

Lennard, Anne, et al.. (1999). Management of non-Hodgkin's lymphomas. Postgraduate Medical Journal. 75(879). 2–6. 15 indexed citations

15.

Lennard, Anne, et al.. (1999). Analysis of CD34 populations in mobilised peripheral blood stem cell harvests and in bone marrow by fluorescent in situ hybridisation for the bcr/abl gene fusion in patients with chronic granulocytic leukaemia. Leukemia. 13(6). 944–949. 5 indexed citations

16.

Finney, R., et al.. (1998). Molecular remission in Philadelphia-positive adult acute lymphoblastic leukaemia rapidly induced by conventional-dose chemotherapy. Bone Marrow Transplantation. 21(3). 323–325. 1 indexed citations

17.

Jackson, G, et al.. (1994). Rapid onset of chronic granulocytic leukaemia after treatment for Hodgkin's disease. British Journal of Haematology. 87(1). 193–195. 10 indexed citations

18.

Stuart, Graham, et al.. (1993). Cytogenetic abnormalities in a disseminated medulloblastoma. Medical and Pediatric Oncology. 21(4). 295–298. 6 indexed citations

19.

Lennard, Anne, Peter Carey, Graham Jackson, & Stephen J. Proctor. (1990). An effective oral combination in advanced relapsed Hodgkin’s disease prednisolone, etoposide, chlorambucil and CCNU. Cancer Chemotherapy and Pharmacology. 26(4). 301–305. 18 indexed citations

20.

Lennard, T.W.J. & Anne Lennard. (1980). Spontaneous disappearance of psoriasis as presenting feature of oat-cell carcinoma of lung.. BMJ. 281(6253). 1460.2–1461. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact